Zinc status and cytokine profile in pediatric Hodgkin's disease

Journal of Trace Elements in Experimental Medicine

Volumn 14, Issue 1, 2001, Pages 25-30

  Ünal, Emel ^a,b   Çavdar, Ayhan O ^a   Babacan, Emel ^a   Gözdaşoǧlu, Sevgi ^a   Yavuz, Gülsan ^a   Ikincioǧullari, Aydan ^a   Akar, Ece ^a   Cin, Şükrü ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Cytokine profile; Hodgkin's disease; Zinc

Indexed keywords

CYTOKINE; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ADOLESCENT; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAIR; HODGKIN DISEASE; HUMAN; MALE; NUTRITIONAL STATUS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; ZINC BLOOD LEVEL;

EID: 0035156267     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-670X(2001)14:1<25::AID-JTRA1004>3.3.CO;2-W     Document Type: Conference Paper

References (20)

1. Zinc deficiency in Hodgkin's disease
2. Zinc and anergy in pediatric Hodgkin's disease in Turkey
3. Changes of zinc values in children during malignant disease
4. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease
5. High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease
6. Serum interleukin-2 receptor: Clinical and biological implications
7. The soluble interleukin-2 receptor: Biology, function and clinical application
8. Serum levels of interleukin-2 receptor in Hodgkin disease
9. Plasma soluble interleukin 2 receptor levels in patients with malignant lymphoma are correlated with disease activity but not cellular immunosuppression
10. Immunohistological analysis of Tac expression in tissues involved by Hodgkin's disease
11. Hodgkin's Disease
12. Periperal blood lymphocytes from patients with cancer lack interleukin-2 receptors
13. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro
14. Elevated circulating levels of TNF-α and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients
15. Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients
16. Tumor necrosis factor cachectin and lymphotoxin gene expression in lymph nodes from lymphnoma patients
17. Cytokine (Interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-6)-possessing cells in lympho nodes of malignant lymphoma
18. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lympadenopathy type
19. Evidence for tumour necrosis factor/cachectin production in cancer patients
20. Tumor necrosis factor-α alters maternal and embryonic zinc metabolism and is developmentally toxic in mice